Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- Check6 days agoChange DetectedThe page’s displayed revision/version was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s interface/versioning rather than the underlying clinical trial information.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange Detected- Revision tag updated from v3.4.3 to v3.5.0, indicating a minor update. No changes to study details or eligibility information were observed.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision label updated to v3.4.2 (replacing v3.4.1); no study details, eligibility criteria, results, or other core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed. This is a minor frontend labeling change with no impact on study details.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.